Birchview Capital, LP Portfolio Holdings
Birchview Capital, LP
- $108 Million
- Q3 2024
Birchview Capital, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $108 Million distributed in 62 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $35.5M, Biodesix Inc with a value of $9.86M, Acadia Pharmaceuticals Inc with a value of $6.16M, United Therapeutics Corp with a value of $3.58M, and Prothena Corp Public LTD CO with a value of $3.51M.
Examining the 13F form we can see an increase of $8.32M in the current position value, from $100M to 108M.
Birchview Capital, LP is based out at Burlington, VT
Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.